Clinical Outcomes of Tislelizumab Combined with Chemotherapy As Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This is an observational study evaluating the clinical characteristics, treatment patterns, and clinical outcomes in Stage III (cTNM-IIIB/IIIC) Non-Small Cell Lung Cancer.Patients meeting inclusion and exclusion criteria were enrolled, with treatment modalities and clinical outcomes of stage III non-small cell lung cancer (NSCLC) patients from multiple tertiary hospitals in real-world settings since August 2020 being collected and analyzed.
Epistemonikos ID: a469b81663634650e055434585a0da3f5116651b
First added on: Mar 01, 2025